You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ERNA Award Disclosure
Cicala Peter · SEC Form 4 · Filed Sep 1, 2026
Award
Calculated transaction value
$0
Cicala Peter Director
ERNA
Transaction date
Aug 31, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 1 day later
ERNA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to buy) on Common Stock
- Quantity / price
- 5,083 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-041135
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ernexa Therapeutics Inc. ERNA | Award | Aug 31, 2026 | $0 |
| Ernexa Therapeutics Inc. ERNA Current | Award | Aug 31, 2026 | $0 |